+86-15212299029
- All
- Product Name
- Product Keyword
- Product Model
- Product Summary
- Product Description
- Multi Field Search
Views: 220 Author: tcchems Publish Time: 2025-07-21 Origin: Site
Content Menu
● Introduction to Glucuronic Acids
>> Beta-D-Glucopyranosiduronic Acid
● Key Differences Between Beta-D-Glucopyranosiduronic Acid and Beta-D-Glucosiduronic Acid
● Biological and Pharmacological Roles
>> Detoxification and Metabolism
>> Prodrug Development and Enzymatic Activation
● Chemical Synthesis and Derivatives
● Applications in Medicine and Research
● Chemical Identification and Database References
● Frequently Asked Questions (FAQs)
Understanding the subtle distinctions between structurally similar biochemical compounds is crucial for researchers and practitioners in chemistry, biochemistry, and pharmacology. Two such compounds often discussed in glycoscience and metabolic studies are Beta-D-Glucopyranosiduronic Acid and Beta-D-Glucosiduronic Acid. Although their names appear nearly identical, these molecules exhibit important differences in structure, function, and biological relevance that impact their roles in metabolism, drug delivery, and biochemical pathways.
Both Beta-D-Glucopyranosiduronic Acid and Beta-D-Glucosiduronic Acid belong to the broader class of glucuronic acids, which are derivatives of glucose where a primary alcohol group is oxidized to a carboxylic acid. These acids are often functionalized forms of glucose that participate in conjugation reactions, increasing water solubility and facilitating excretion of substances in metabolism.
Glucuronic acid occurs in biological systems primarily as beta-D-glucopyranuronic acid, where the sugar is in a six-membered pyranose ring form with a beta-configuration at the anomeric carbon. This structure enables it to form glycosidic bonds and participate in pathways such as detoxification and drug metabolism.
- This molecule is a beta-D-glucopyranuronic acid, meaning it features a glucose-derived pyranose (six-membered) ring in the beta configuration, with a carboxylic acid replacing the traditional primary alcohol at carbon-6.
- The term "pyranosiduronic" emphasizes the pyranose ring structure coupled with the uronic acid functionality.
- It is commonly found as a metabolite and conjugate acid of beta-D-glucuronate.
- Molecular weight is around 194 g/mol with the formula implicating six carbons in the sugar core and one carboxyl group.
- Its beta anomeric center configuration is critical for its biological roles in enzyme recognition and glycosidic bond formation.
- It serves as a key building block in biological conjugates, especially in forming glucuronides with drugs and steroids enhancing their solubility and facilitating elimination.
- Structurally, beta-D-Glucopyranosiduronic acid also forms derivatives where multiple functional groups are attached, influencing its reactivity and biological function.
- Beta-D-Glucosiduronic acid is a more general term representing glucosiduronic acid derivatives, broadly referencing molecules resulting from formal condensation with beta-D-glucuronic acid.
- It is often used synonymously with beta-D-glucuronides, the conjugated forms of glucuronic acid with other substances through glycosidic bonds.
- This term points to molecules arising from glycosidic bonds formed via beta-D-glucuronic acid but not necessarily restricted to a single pyranose ring.
- It can refer to a class of compounds that behave as glucuronides, which include a wide variety of conjugated molecules in metabolism.
- The term "glucosiduronic" suggests these molecules have uronic acid content derived from glucose but may vary in substitution patterns and glycosidic linkages.
| Feature | Beta-D-Glucopyranosiduronic Acid | Beta-D-Glucosiduronic Acid |
|---|---|---|
| Chemical Structure | Defined pyranose (six-membered) ring with uronic acid group | Broader class of glucuronides formed by condensation with glucuronic acid |
| Specificity | Specific to beta-D-glucopyranuronic acid | General term for glucuronide derivatives acting as glycosiduronic acids |
| Functional Role | Metabolite and glucuronyl donor in conjugation reactions | Formed by attaching substances to glucuronic acid via glycosidic bonds |
| Biological Context | Found as free acid or conjugated forms, key in metabolism | Describes glucuronides facilitating excretion of xenobiotics and steroids |
| Molecular Weight | Approx. 194 g/mol | Variable, depending on conjugated moiety |
| Example Usage in Biology | Basic building block for glucuronide prodrugs and metabolites | Encompasses all glucuronide conjugates including drug and steroid metabolites |
Both molecules are central to glucuronidation, a biochemical process where xenobiotics, drugs, and endogenous compounds are conjugated with glucuronic acid to increase water solubility. This process facilitates their removal via urine or bile, effectively detoxifying potentially harmful substances.
Beta-D-Glucopyranosiduronic acid is the canonical form in which glucuronic acid is linked to substrates enzymatically to produce glucuronides. Beta-D-Glucosiduronic acid denotes the broader class of these glucuronide conjugates.
Glucuronides, derived from beta-D-glucopyranosiduronic acid, are increasingly used in targeted prodrug therapies, especially for cancer. They exhibit low cytotoxicity with enhanced solubility and can be selectively activated at tumor sites via enzymes such as β-D-glucuronidase, releasing the active drug locally.
The distinction is important because understanding the structure of the glucuronide (specific beta-D-glucopyranosiduronic acid conjugation) informs design criteria for stability, solubility, and enzymatic release in therapeutic contexts.
Synthesis of glucuronide conjugates typically relies on the reactivity and stereochemistry of the beta-D-glucopyranosiduronic acid moiety. Specific methods controlling the glycosidic bond configuration and site of substitution impact yield and biological function. The substitution pattern in glucosiduronic acid derivatives can significantly influence bioactivity.
Examples include glycosylation strategies using trichloroacetimidate donors or enzymatic syntheses to obtain specific conjugates with therapeutic or diagnostic applications.
- Drug metabolism studies: Beta-D-glucopyranosiduronic acid conjugates help probe drug absorption, biotransformation, and elimination.
- Cancer therapy: Glucuronide prodrugs designed from beta-D-glucopyranosiduronic acid are activated at tumors.
- Biochemical probes: Glucosiduronic acid derivatives serve as labels or substrates for enzymatic assays.
- Steroid metabolism: Estrogen conjugates like estriol 3-glucuronide (a form of beta-D-glucosiduronic acid conjugate) indicate hormone metabolism status.
- Glycoscience: Elucidation of structure-function relationships in polysaccharides and proteoglycans containing glucuronic acid components.
Beta-D-Glucopyranosiduronic acid is well-characterized in chemical databases (e.g., PubChem), exhibiting a distinct molecular formula, weight, and defined 2D chemical structure with beta-configuration of the glucuronic acid unit.
Beta-D-Glucosiduronic acid, as a generic term or ChEBI ontology entity, covers multiple conjugates with diverse biological and chemical variations. It is used to classify glucuronides that share a common glucuronic acid origin yet differ in attached molecules or glycosidic linkages.
1. What is the core structural difference between beta-D-Glucopyranosiduronic acid and beta-D-Glucosiduronic acid?
Beta-D-Glucopyranosiduronic acid specifically refers to the beta-configured pyranose form of glucuronic acid, whereas beta-D-Glucosiduronic acid broadly refers to glucuronide conjugates formed by glycosidic bonds involving glucuronic acid.
2. How do these two compounds contribute to drug metabolism?
Beta-D-Glucopyranosiduronic acid forms the scaffold for glucuronidation, enhancing drug solubility and excretion. Beta-D-Glucosiduronic acid represents the formed conjugates which are excreted or enzymatically cleaved to release active drug molecules.
3. Why is the beta configuration important in glucuronic acid conjugates?
The beta configuration at the anomeric carbon determines the specificity and stability of glycosidic bonds, affecting enzymatic recognition and biological activity of glucuronides.
4. Can both compounds be used in cancer prodrug therapy?
Yes, beta-D-Glucopyranosiduronic acid derivatives are used to design glucuronide prodrugs that are selectively activated in tumor tissues by enzymes like beta-D-glucuronidase.
5. Are beta-D-Glucosiduronic acid and beta-D-Glucopyranosiduronic acid interchangeable terms?
No, beta-D-Glucopyranosiduronic acid is a specific chemical entity, while beta-D-Glucosiduronic acid refers more broadly to glucuronic acid-containing conjugates.
[1] https://ontosight.ai/glossary/term/beta-d-glucopyranosiduronic-acid-properties--67a28ab0c445bf945af24ec9
[2] https://pubchem.ncbi.nlm.nih.gov/compound/158254
[3] https://pmc.ncbi.nlm.nih.gov/articles/PMC6263331/
[4] https://pubchem.ncbi.nlm.nih.gov/compound/440305
[5] https://www.sciencedirect.com/topics/medicine-and-dentistry/glucuronic-acid
[6] https://pubchem.ncbi.nlm.nih.gov/compound/158253
[7] https://en.wikipedia.org/wiki/Estriol_3-glucuronide
[8] https://pubchem.ncbi.nlm.nih.gov/compound/122361323
[9] https://commonchemistry.cas.org/detail?cas_rn=65535-18-4
[10] https://pubchem.ncbi.nlm.nih.gov/compound/beta-D-Glucopyranuronic%20acid
[11] https://zfin.org/ZDB-TERM-160831-136781
Hot Tags: China, Global, OEM, private label, manufacturers, factory, suppliers, manufacturing company
